Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011216 |
---|---|
Receipt number | R000012975 |
Scientific Title | Combination chemotheraoy of abraxane and carboplatin in elderly patients with advanced squamous cell lung cancer, phase 1/2 study (TORG1322) |
Date of disclosure of the study information | 2013/07/18 |
Last modified on | 2020/11/26 10:10:55 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/07/18 10:31:30 | ||
2 | Update | 2014/01/20 07:40:11 | Address Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL |
|
3 | Update | 2014/04/08 10:17:46 | Division name Address Division name Address |
|
4 | Update | 2014/04/08 11:00:26 | Division name Division name |
|
5 | Update | 2014/07/18 10:32:15 | Email |
|
6 | Update | 2016/05/19 13:34:13 | Name of primary person or sponsor Organization Organization Organization Category of Funding Organization |
|
7 | Update | 2018/10/24 10:35:17 | Recruitment status Last follow-up date |
|
8 | Update | 2019/04/24 09:23:53 | Recruitment status Date of IRB Anticipated trial start date |
|
9 | Update | 2020/07/13 16:40:09 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
10 | Update | 2020/11/26 10:10:55 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Address Address Organization Organization Address Address Tel |